{
  "Q0": "Whole exome sequencing (WES) to investigate potential genetic causes of neurodevelopmental delay and seizures",
  "Q1": "Yes",
  "Q2": "Yes",
  "Q3": "Yes",
  "Q4": "No",
  "Q5": "Yes",
  "Q6": "No",
  "Q7": "Yes",
  "Q8": "No",
  "Q9": "Yes",
  "Q10": "No",
  "Q10_followup": "Diagnostic",
  "Q11": "Yes",
  "Q12": "No",
  "Q13": "Yes",
  "Q14": "Not listed",
  "Q15": "No",
  "Q16": "Yes",
  "Q17": "Based on the policy, the following steps should be followed: 1) Ensure prior authorization is obtained before conducting the test; 2) Document that the patient meets medical necessity criteria including neurodevelopmental delay, seizures, and negative prior CMA testing; 3) Include documentation from the genetic counselor who ordered the test; 4) Submit clinical notes documenting the family history of neurodevelopmental disorders; 5) Include the results of the previous chromosomal microarray test showing it was negative; 6) Provide justification for how the test results will impact clinical management of the patient's condition."
}